Showing results (1371-1380 of 3,615) with videos related to

Sort By:
Pageof 362
Journal of Viral Hepatitis|April 14, 2006
Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosisY-F Liaw, C-M Lee, R-N Chien, et al.
Journal of Viral Hepatitis|April 14, 2006
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experienceH L Tillmann, J Hadem, L Leifeld, et al.
Journal of Viral Hepatitis|August 12, 2006
Viral kinetics in the treatment of chronic hepatitis CJennifer E Layden-Almer, Scott J Cotler, Thomas J Layden
Journal of Viral Hepatitis|August 12, 2006
Identification of T-cell epitopes associated with immunity within the surface protein of duck hepatitis B virusR Welschinger, Y Cossart, J Pouliopoulos, et al.
Journal of Viral Hepatitis|August 12, 2006
Plasma ribavirin concentrations during treatment of recurrent hepatitis C with peginterferon alpha-2b and ribavirin combination after liver transplantationJ Dumortier, E Ducos, J-Y Scoazec, et al.
Journal of Viral Hepatitis|August 12, 2006
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1C Brandão, A Barone, F Carrilho, et al.
Journal of Viral Hepatitis|August 16, 2006
Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replicationT Kohashi, S Maekawa, N Sakamoto, et al.
Journal of Viral Hepatitis|September 15, 2006
Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patientsC Christensen, D Bruden, S Livingston, et al.
Journal of Viral Hepatitis|September 15, 2006
Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replicationY Itsui, N Sakamoto, M Kurosaki, et al.
Journal of Viral Hepatitis|July 18, 2006
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patientsA Cozzi, A L Zignego, R Carpendo, et al.
Pageof 362